Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device labelling review planned in Australia:

This article was originally published in Clinica

Executive Summary

Australia's Therapeutic Devices Branch (TDB) is to undertake a review of the existing legislation covering labelling of medical devices, says the Australian Therapeutic Device Bulletin. Issues identified for consideration include sterility, pyrogenicity and warning statements relating to scheduled poisons or the observation of precautions. The TDB also believes there is a need to make more product information available to device users and consumers. Depending on the product, this information could include: instructions for use; explanation of possible risks/benefits; general warnings/precautions; set-up and check-out procedures; cleaning procedures; and maintenance, troubleshooting and storage information, the TDB suggests.

Topics

UsernamePublicRestriction

Register

MT090529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel